Pharmaceuticals, Biotechnology and Life Sciences
Dr. Srinivasan provides 30 years of broad regulatory and drug development experience including a career serving as Director of CMC…
Reports Second Quarter 2021 Revenues of $6.9 Million and Third Consecutive Quarter of Positive Adjusted EBITDA(1) PORTLAND, Ore., Aug. 26,…
NEW YORK, Aug. 26, 2021 (GLOBE NEWSWIRE) — Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), a gene-editing…
Shares of Aadi to commence trading on the Nasdaq Capital Market on August 27, 2021 under ticker symbol “AADI”Concurrent $155…
Kathleen Sebelius Chair of Humacyte’s Board of Directors Dr. Laura Niklason Founder, President & CEO of Humacyte Rajiv Shukla CEO…
Innovent will provide proprietary antibodies for selected tumor targets and Bolt will provide its proprietary Boltbody™ technology to create new…
WAYNE, Pa., Aug. 26, 2021 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing…
Successfully closed $345 million upsized IPO in July 2021 On track to initiate multiple HERKULES Phase 1b/2 trials in 2021…
TORONTO, Aug. 26, 2021 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (FRA: 20MP)…
Strong pipeline of opportunities across all three strategic pillarsWINNIPEG, Manitoba, Aug. 26, 2021 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-…